PortViewPortView
ISRL logo

Defiance KSM Israel 120 (ISRL) ETF Holdings & Analysis

ETFOther

$23.38-6.55%
1-year price historyRange $11.17 – $25.83
52-week range$23.38
$11.86$26.98

Track ISRL in your portfolio for free · Portfolio tracker

What ISRL does

The Defiance KSM Israel 120 ETF (the Fund) seeks to track the performance, before fees and expenses, of the Israeli 120 iNDEX (the Index).

Fund profile

Category
Other
AUM
$1.17M
Holdings
10
52-week high
$26.98
52-week low
$11.86

Top holdings

Top 1037%
HoldingWeight
Bank Hapoalim BM4.48%
Bank Leumi Le-Israel BM4.46%
Mizrahi Tefahot Bank Ltd4.33%
Elbit Systems Ltd4.32%
Teva Pharmaceutical Industries Ltd3.58%
Azrieli Group Ltd3.42%
Tower Semiconductor Ltd3.40%
Phoenix Financial Ltd3.32%
Israel Discount Bank Ltd3.01%
Harel Insurance Investments & Financial Services Ltd2.83%

Geographic allocation

Israel97.48%
United States1.08%
Singapore0.75%
United Kingdom0.28%
Other0.21%
Netherlands0.21%

PortView Portfolio Insights

PortView analyzes how ISRL fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ISRL in PortView →

Related securities

Related stocks

Frequently asked questions

What does ISRL track?
ISRL is the Defiance KSM Israel 120 ETF, a Other ETF.
What is the expense ratio of ISRL?
Expense ratio data for ISRL is shown on the page when available from our data provider.
What are the largest holdings in ISRL?
Top holdings include POLI.TA, LUMI.TA, MZTF.TA, ESLT.TA, TEVA.TA.
How can PortView analyze ISRL overlap with other ETFs?
PortView computes the holdings overlap between ISRL and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.